Prevalence of scabies and impetigo worldwide: a systematic review

被引:259
|
作者
Romani, Lucia [1 ]
Steer, Andrew C. [2 ,3 ,4 ]
Whitfeld, Margot J. [5 ]
Kaldor, John M. [1 ]
机构
[1] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia
[2] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia
[3] Murdoch Childrens Res Inst, Grp A Streptococcal Res Grp, Melbourne, Vic, Australia
[4] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic, Australia
[5] St Vincents Hosp, Dept Dermatol, Sydney, NSW 2010, Australia
来源
LANCET INFECTIOUS DISEASES | 2015年 / 15卷 / 08期
基金
英国医学研究理事会;
关键词
PRIMARY-SCHOOL CHILDREN; SKIN DISEASES; HEALTH-CARE; IVERMECTIN; COMMUNITY; EPIDEMIOLOGY; INFECTIONS; DISORDERS; COMMON; DERMATOLOGY;
D O I
10.1016/S1473-3099(15)00132-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Scabies is a skin disease that, through secondary bacterial skin infection (impetigo), can lead to serious complications such as septicaemia, renal disease, and rheumatic heart disease. Yet the worldwide prevalence of scabies is uncertain. We undertook a systematic review, searching several databases and the grey literature, for population-based studies that reported on the prevalence of scabies and impetigo in a community setting. All included studies were assessed for quality. 2409 articles were identified and 48 studies were included. Data were available for all regions except North America. The prevalence of scabies ranged from 0.2% to 71.4%. All regions except for Europe and the Middle East included populations with a prevalence greater than 10%. Overall, scabies prevalence was highest in the Pacific and Latin American regions, and was substantially higher in children than in adolescents and adults. Impetigo was common, particularly in children, with the highest prevalence in Australian Aboriginal communities (49.0%). Comprehensive scabies control strategies are urgently needed, such as a community-based mass drug administration approach, along with a more systematic approach to the monitoring of disease burden.
引用
收藏
页码:960 / 967
页数:8
相关论文
共 50 条
  • [1] Systematic review of the global prevalence of scabies and impetigo
    Romani, L.
    Steer, A. C.
    Whitfeld, M. J.
    Kaldor, J. M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 19 - 19
  • [2] Prevalence of scabies worldwide-An updated systematic literature review in 2022
    Schneider, S.
    Wu, J.
    Tizek, L.
    Ziehfreund, S.
    Zink, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1749 - 1757
  • [3] The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma
    Bowen, Asha C.
    Mahe, Antoine
    Hay, Roderick J.
    Andrews, Ross M.
    Steer, Andrew C.
    Tong, Steven Y. C.
    Carapetis, Jonathan R.
    PLOS ONE, 2015, 10 (08):
  • [4] Scabies and impetigo
    Moor, F
    BRITISH MEDICAL JOURNAL, 1943, 1943 : 761 - 762
  • [5] Scabies and Impetigo
    Dick, JS
    BRITISH MEDICAL JOURNAL, 1942, 1942 : 340 - 340
  • [6] Prevalence of scabies and impetigo in the Solomon Islands: a school survey
    Osti, Millicent H.
    Sokana, Oliver
    Phelan, Sophie
    Marks, Michael
    Whitfeld, Margot J.
    Gorae, Christina
    Kaldor, John M.
    Steer, Andrew C.
    Engelman, Daniel
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [7] Scabies and Impetigo
    Freeman, Charles D.
    AMERICAN JOURNAL OF NURSING, 1934, 34 (09) : 857 - 859
  • [8] Scabies and impetigo
    Gray, AMH
    BRITISH MEDICAL JOURNAL, 1943, 1943 : 830 - 830
  • [9] Prevalence of scabies and impetigo in the Solomon Islands: a school survey
    Millicent H. Osti
    Oliver Sokana
    Sophie Phelan
    Michael Marks
    Margot J. Whitfeld
    Christina Gorae
    John M. Kaldor
    Andrew C. Steer
    Daniel Engelman
    BMC Infectious Diseases, 19
  • [10] Worldwide Prevalence of Polypharmacy: A Systematic Review
    Januario, Beatriz Dias
    Mafra, Natalia Silva
    Silva, Humberto de Souza
    Carvalho, Isabella Monteiro
    Sena, Ana Luiza Sobreira
    Pereira, Ana Paula Gomes Soares
    de Faria Junior, Newton Santos
    Campos, Helton Oliveira
    CURRENT DRUG METABOLISM, 2023, 24 (08) : 568 - 586